source
- Star Therapeutics raises $200 million to build new drug pipeline after Vega and Electra winsStar Therapeutics announced it has secured $200 million in financing. The capital will be used to develop its own pipeline of medicines, aiming to replicate the success of its earlier Vega and Ele…
- Alnylam to launch larger study of RNA therapy for Huntington’s diseaseAlnylam Therapeutics announced it will expand its clinical program for an RNA‑based drug aimed at treating Huntington’s disease. The decision comes amid a challenging landscape for neurodegenerati…